Bacteria had to compete with a standard antibiotic for the best treatment option of repeated urinary tract infections (UTI).Bacteria had to compete with a standard antibiotic for the best treatment option of repeated urinary tract infections (UTI).
Dutch researchers conducted a randomized placebo-controlled trial that involved 250 postmenopausal women (an age group at higher risk) with histories of at least three UTIs in the previous year. The women received either a standard dose of the antibiotic Trimethprim-Sulfamethoxazole once at night time or a standard dose of Lactobacillus rhamnosus and Lactobacillus reuteri twice daily.
Dutch researchers conducted a randomized placebo-controlled trial that involved 250 postmenopausal women (an age group at higher risk) with histories of at least three UTIs in the previous year. The women received either a standard dose of the antibiotic Trimethprim-Sulfamethoxazole once at night time or a standard dose of Lactobacillus rhamnosus and Lactobacillus reuteri twice daily.